Search:
Home | Register or Login | Contact Us

Literature Summaries More

Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes
Holman RR, Thorne KI, Farmer AJ, et al; 4-T Study Group. N Engl J Med. 2007;357:1716-1730.

Exenatide Therapy in Obese Patients With Type 2 Diabetes Mellitus Treated With Insulin
Viswanathan P, Chaudhuri A, Bhatia R, Al-Atrash F, Mohanty P, Dandona P. Endocr Pract. 2007;13:444-450.

Results of the Glucose-Lowering Effect of Welchol Study (GLOWS): a Randomized, Double-Blind, Placebo-Controlled Pilot Study Evaluating the Effect of Colesevelam Hydrochloride on Glycemic Control in Subjects With Type 2 Diabetes
Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL. Clin Ther. 2007;29:74-83.


 

 
SPOTLIGHT ON TYPE 2 DIABETES
CME-Certified Activities:
Cases In Practice: Incretin-Based Therapies for Common Patient Encounters
Peak Issues 2: Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes
The Evolving Landscape of Incretin-Based Therapies: Evaluating Recent Data and Its Clinical Applications
Clinical Practice Poll
In your opinion, where do incretin mimetics fit into the treatment paradigm for type 2 diabetes?
First-line monotheray
First-line combination therapy with oral agents
After failing 1 oral agent
After failing 2 oral agents
About Us | Terms of Use | Privacy Statement | Disclaimer